What is interesting is how many millions this small company have raised from foundations to do their trials.
Pharmacyte often says they are discussing funding with foundations. If this company can raise millions in a prediabetic treatment how come pcmb can't raise some for Mellingen cells or pancreatic cancer treatment?
Where's the foundation money ? While our CEO is getting a massive pay increase why isn't he raising some foundation money for trials or at least giving us an update on their funding efforts? He says he is having discussions with these foundations but where are the results?
It's much more complicated than that. Sounds like they are looking for early signs of beta cell failure in individuals who may have a predisposition to type 1 diabetes. I'm glad they're getting funding...sounds promising.
Market Data 
Markets 
AI
